REGN vs RPRX: Fair Value Comparison

Regeneron Pharmaceuticals Inc vs. Royalty Pharma Plc · Biotechnology

REGN's model fair value sits 24.8% above its current price; RPRX's model fair value sits 32.1% below its current price. Of the two, REGN trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

REGNRPRX
Price$821.12$63.96
Model fair value (multi-method blend)$1024.52$43.42
Model fair value differential+24.8%-32.1%
Methods with a model value above price5 of 116 of 8
Fundamental strengthBB
Next earnings report2026-10-302026-11-04

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

VRTX vs REGN · REGN vs ARGX · REGN vs ONC · REGN vs ALNY · VRTX vs RPRX · ARGX vs RPRX · ONC vs RPRX · RPRX vs ALNY · All Biotechnology stocks · Compare any two stocks